Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;24(11):e2300062.
doi: 10.1002/pmic.202300062.

Extracellular vesicle proteins as breast cancer biomarkers: Mass spectrometry-based analysis

Affiliations
Review

Extracellular vesicle proteins as breast cancer biomarkers: Mass spectrometry-based analysis

Raju Bandu et al. Proteomics. 2024 Jun.

Abstract

Extracellular vesicles (EVs) are membrane-surrounded vesicles released by various cell types into the extracellular microenvironment. Although EVs vary in size, biological function, and components, their importance in cancer progression and the potential use of EV molecular species to serve as novel cancer biomarkers have become increasingly evident. Cancer cells actively release EVs into surrounding tissues, which play vital roles in cancer progression and metastasis, including invasion and immune modulation. EVs released by cancer cells are usually chosen as a gateway in the search for biomarkers for cancer. In this review, we mainly focused on molecular profiling of EV protein constituents from breast cancer, emphasizing mass spectrometry (MS)-based proteomic approaches. To further investigate the potential use of EVs as a source of breast cancer biomarkers, we have discussed the use of these proteins as predictive marker candidates. Besides, we have also summarized the key characteristics of EVs as potential therapeutic targets in breast cancer and provided significant information on their implications in breast cancer development and progression. Information provided in this review may help understand the recent progress in understanding EV biology and their potential role as new noninvasive biomarkers as well as emerging therapeutic opportunities and associated challenges.

Keywords: biomarker; cancer; extracellular vesicles; mass spectrometry; proteins.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. O'driscoll, L. (2015). Expanding on exosomes and ectosomes in cancer. New England Journal of Medicine, 372, 2359–2362.
    1. Jang, S. C., Kim, S. R., Yoon, Y. J., Park, K.‐S., Kim, J. H., Lee, J., Kim, O. Y., Choi, E.‐J., Kim, D.‐K., Choi, D.‐S., Kim, Y.‐K., Park, J., Di Vizio, D., & Gho, Y. S. (2015). In vivo kinetic biodistribution of nano‐sized outer membrane vesicles derived from bacteria. Small, 11, 456–461.
    1. Witwer, K. W., Goberdhan, D. C., O'driscoll, L., Théry, C., Welsh, J. A., Blenkiron, C., Buzás, E. I., Di Vizio, D., Erdbrügger, U., Falcón‐Pérez, J. M., Fu, Q.‐L., Hill, A. F., Lenassi, M., Lötvall, J., Nieuwland, R., Ochiya, T., Rome, S., Sahoo, S., & Zheng, L. (2021). Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. Journal of Extracellular Vesicles, 10, e12182.
    1. Gould, S. J., & Raposo, G. (2013). As we wait: Coping with an imperfect nomenclature for extracellular vesicles. Journal of Extracellular Vesicles, 2, 20389. https://doi.org/10.3402/jev.v2i0.20389
    1. Théry, C., Ostrowski, M., & Segura, E. (2009). Membrane vesicles as conveyors of immune responses. Nature Reviews Immunology, 9, 581–593.

Substances

LinkOut - more resources